The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System
Payments companies reported to CMS as associated with The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System
These are the largest totals companies reported as associated with The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jenny Zablah Alabi | Aurora, CO | Interventional Cardiology | $21,204.90 |
| Jamil Aboulhosn | Los Angeles, CA | Cardiovascular Disease | $14,489.87 |
| Daniel Levi | Los Angeles, CA | Pediatric Cardiology | $12,333.61 |
| Aimee Armstrong | Columbus, OH | Pediatric Cardiology | $11,882.16 |
| Vasiliki Dimas | Dallas, TX | Pediatric Cardiology | $10,962.99 |
| Evan Zahn | Los Angeles, CA | Interventional Cardiology | $6,452.97 |
| Gareth Morgan | Aurora, CO | Interventional Cardiology | $5,991.16 |
| Shabana Shahanavaz | Cincinnati, OH | Pediatric Cardiology | $5,547.53 |
| Alejandro Torres | New York, NY | Pediatric Cardiology | $5,298.42 |
| Mark Law | Birmingham, AL | Pediatric Cardiology | $4,293.91 |
Prescribed The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.